Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Expression of Ccl11 Associates with Immune Response Modulation and Protection against Neuroinflammation in Rats.
CCSVI is associated with multiple sclerosis.
Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.
Alcohol as a Modifiable Lifestyle Factor Affecting Multiple Sclerosis Risk.
No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis.
Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Active Biotech's partner Teva initiates a laquinimod clinical trial in Huntington's disease
Association of Viruses in Neurodegenerative and Neurobehavioral Diseases.
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial.
Large-scale neuronal network dysfunction in multiple sclerosis?: Evidence from resting-state fMRI.
Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial.
Longitudinal Penalized Functional Regression for Cognitive Outcomes on Neuronal Tract Measurements.
[Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : A systematic review.]
A small-molecule screen yields idiotype-specific blockers of neuromyelitis optica-immunoglobulin G binding to aquaporin-4.
Multiple sclerosis, blood flow, and CSF circulation.
The underdiagnosis of sleep disorders in patients with multiple sclerosis.
Astrocytes Promote Oligodendrogenesis after White Matter Damage via Brain-Derived Neurotrophic Factor.
The effects of robot-assisted gait training in progressive multiple sclerosis: A randomized controlled trial.
Multiple sclerosis, cannabis, and cognition: A structural MRI study.
Season of birth as a risk factor for multiple sclerosis in Brazil.
Application of diffusion tensor imaging (DTI) in pathological changes of the spinal cord.
Seasonality of multiple sclerosis and neuromyelitis optica exacerbations in Japan.
Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis.
Reversible blindness in bilateral optic neruritis associated with nasal flu vaccine.
Pages
« first
‹ previous
…
240
241
242
243
244
245
246
247
248
…
next ›
last »